New Drug UB-312 Shows Promise in Treating Parkinson's Disease

A new drug, UB-312, is showing promise in relieving symptoms of Parkinson's disease by targeting toxic proteins in the brain. The drug is being tested in phase 1 trials and has shown positive effects on patients' daily movement. The ultimate goal is to develop disease-modifying treatments for Parkinson's.

Breakthrough in Cryogenics: Freezing and Thawing Human Brain Tissue

Scientists in China have successfully frozen and thawed human brain tissue, leading to the potential ability to freeze and bring back brains to life. The new technique could revolutionize neurological studies and possibly lead to the cryopreservation of entire brains in the future.